Short answer
Emergent BioSolutions Inc. (EBS) filed an 8-K current report with the SEC on April 30, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 78.12% turnout, with 40,346,672 shares represented at the annual meeting.
Emergent BioSolutions Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 78.12% turnout, with 40,346,672 shares represented at the annual meeting
- All four Class II director nominees elected through 2029, including Joseph Papa and Zsolt Harsanyi
- Ernst & Young ratified as independent auditor for fiscal 2026, with 38,947,477 votes supporting
- Executive compensation approved, but relatively narrow support at 18,187,878 votes versus 11,988,552 against
- Stock incentive plan share increase approved, with 16,972,952 votes for and 14,023,162 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Emergent BioSolutions Inc. 8-K filings
Get the next EBS 8-K as it lands
Follow EBS for push alerts, or ask the research agent what this filing means.